TBPH
Theravance Biopharma Inc
17.00$
+0.0%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 39.1% | 35.0% | 33.5% | 33.0% | 32.7% | 45.5% | 43.7% | 86.0% | 85.4% | 86.2% | 88.4% | 88.7% | |
| 17.3% | 10.4% | 14.5% | 12.8% | 6.6% | 10.7% | 32.2% | 66.2% | 42.1% | 34.6% | 61.0% | 46.8% | |
| 32.4% | 26.8% | 26.9% | 26.5% | 25.7% | 24.9% | 38.1% | 79.5% | 79.4% | 64.9% | 83.6% | 82.5% | |
| 4.1% | 4.6% | 3.9% | 3.9% | 4.7% | 19.3% | 4.5% | 5.1% | 4.4% | 19.7% | 3.3% | 4.3% | |
| 0.4% | 0.0% | – | – | -4.9% | – | – | – | – | – | – | – | |
| 40.5% | 44.2% | 44.8% | 46.5% | 47.9% | 50.4% | 51.7% | 47.2% | 44.0% | 38.9% | 38.5% | 38.3% | |
| 6.1% | 6.5% | 5.8% | 6.3% | 6.6% | 9.1% | 9.2% | 12.8% | 9.0% | 7.9% | 6.7% | 6.5% | |
| 2.3% | 1.0% | 1.1% | 1.2% | 1.2% | 3.0% | 3.1% | 2.6% | 2.6% | 2.3% | 2.3% | 2.3% | |
| 0.6% | 0.4% | 0.5% | 0.5% | 0.4% | 0.6% | 0.7% | 0.4% | 0.5% | 0.5% | 0.2% | 0.1% | |
| 59.5% | 55.8% | 55.2% | 53.5% | 52.1% | 49.6% | 48.3% | 52.8% | 56.0% | 61.1% | 61.5% | 61.7% | |
| -217.8% | -238.0% | -248.0% | -258.9% | -266.8% | -272.6% | -285.0% | -216.9% | -221.6% | -177.0% | -183.0% | -185.3% | |
| 12.7% | 12.9% | 13.0% | 13.5% | 13.8% | 13.9% | 14.5% | 11.9% | 12.5% | 10.9% | 10.9% | 11.0% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.